UBS downgrades Cytokinetics Inc (CYTK) rating to a Neutral
Cytokinetics Inc’s recently made public that its Director HENDERSON JOHN T unloaded Company’s shares for reported $0.68 million on Apr
Cytokinetics Inc’s recently made public that its Director HENDERSON JOHN T unloaded Company’s shares for reported $0.68 million on Apr
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cytokinetics Inc’s filing revealed that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.42 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc
Cytokinetics Inc’s filing revealed that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.42 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2